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A STUDY OF CLINICAL PROFILE AND SERUM HOMOCYSTEINE 
LEVEL YOUNG STROKE-     EXCLUDING   RISK   FACTORS 
SMOKING, ALCOHOL,HYPERCHOLESTEROLEMIA,HYPERTENSION, 
DIABETES MELLITUS 
ABSTRACT: 
BACKGROUND: 
              Stroke is a common worldwide health problem. It is one of the  major 
cause of morbidity, mortality and disability in developed as well as developing 
countries. Each year there are about one million strokes , making it by far the most 
common neurological disorder. Hyperhomocysteinemia is one of the newly 
recognized factor that increases the risk of vascular disease. In this study we 
evaluated the role of serum homocysteine as individual risk factor for young stroke 
in the absence of smoking, diabetes mellitus, hypercholesterolemia,alcoholism . 
Methodology:  
                      50 patients with young stroke were selected for the study. Patients  
having  Conventional risk factor like hypertension ,diabetes mellitus, smoking, 
hyperlipedemia,  alcoholism  were  excluded  from  the  study. Serum 
homocysteine  was assayed using fluorescence polarization immunoassay. 
Results: Of the  50 patients included in the study 32 patients had elevated  
homocysteine and 18 patients  homocysteine were within normal limit. Hence the 
study shows an increased incidence of stoke in patients with  elevated 
homocysteine and  it was statistically significant. Average serum homocysteine 
level in patients of young stroke with elevated homocysteine  is 34.58  .the average 
homocysteine  level in young stroke  patients  with normal range homocysteine is 
11.8. In our study out of 32 patients with elevated serum homocysteine  there was 
3% hemorrhagic stroke 13% CVT, and the remaining  84%  patients  had  
ischaemic  stroke. 
Conclusion:  
                    Our study shows hyperhomocystenemia in majority of young stroke 
patients  around 64% who did not have the conventional risk factors . Also patients 
with hyperhomocysteinemia  were  more commonly found in the age group of  30-
35years and  hyperhomocysteinemia as a cause of young stroke  was more 
common   among males compared to females. since hyperhomocysteinemia is 
associated with increased incidence of young stroke and recurrent stroke large 
group of well organized study studies has to be conducted to find out whether 
homocysteine lowering therapy with high dose folic acid, pyridoxine and vitamin 
B12 reduces the incidence of young stroke and   recurrent stroke . 
Key Words: young stroke, hyperhomocysteinemia, individual risk factor. 
 
 
1 
 
 
 
 
INTRODUCTION 
 
Stroke is a common worldwide health problem. It is one of the  major 
causes of  morbidity, mortality and disability in developed as well as 
developing countries.   
  Each year there are about one million strokes in the European Union 
making it by far the most common neurological disorder. After coronary 
heart disease and all cancers, stroke is emerging as the third most common 
cause of death in the world, and has caused  nearly 4 million deaths in 1990, 
and three quarters of those deaths in developing countries.   
                                                                       
  
 
 
2 
 
 
                                     AIMS AND OBJECTIVES 
                              To assess serum homocysteine level  as an  individual 
risk factor for young stroke. 
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CLINICAL  ANATOMY. 
Brain comprises  2 - 2.5% of total  body weight and it  Receives around  
15% or of total cardiac output (approx. 750 ml of blood/minute) and it uses   
nearly  20-25% or  ⅟5 of total oxygen of the  whole body.1 
 
Sources of supply to the brain include   two pairs of arterial trunks that form 
a complex  anastomosis (circle of Willis), the Internal carotid artery that 
spplies Forebrain & occipital lobe of cerebrum and the Vertebral artery 
supplies the  Occipital lobe, brainstem &  cerebellum, upper spinal cord. 
Internal Carotid Artery: figure  
It arises from the  Bifurcation of common carotid artery Course includes  an  
Extracranial part  that enters cranial cavity via  carotid canal and an  
Intracranial S-shape curve called carotid siphon 
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Figure 1 
Petrous part of temporal bone  , Side of sphenoid & within cavernous  sinus 
in close relation with CN III, IV, V & VI, reaches base of brain lateral to 
optic  chiasm.the  cerebral course pierces dura mater to reach anterior 
perforated space. 
The  Extracerebral  Branches of Internal Carotid Artery are the  Petrous 
part,Caroticotympanic to tympanic cavity ,Pterygoid artery to pterygoid  
Canal, Cavernous part Meningeal , Hypophysial . After cavernous course 
Ophthalmic branch  to contents of  orbital cavity and 6 Cerebral branches 
Choroidal ,Anterior cerebral,  Middle cerebral artery. 
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Anterior cerebral artery :  
            It is a Smaller terminal branch  of ICA and it has Cortical branches  
supplying  medial surface and  marginal area of superolateral surfaces of 
cerebrum and the Central branches which supply  rostrum of corpus 
callosum, septum pellucidum, putamen, head of nucleus. 
Middle cerebral artery: 
  It is one of the Larger terminal branch of ICA it has  Cortical 
branches which supply  superolateral surface & temporal pole and the 
Central branches  Medial striate which supply caudate nucleus, internal 
capsule, lentiform nucleus,the  Lateral striate branch which supply the  
caudate nucleus.the  Charcot’s artery of cerebral  haemorrhage – largest & 
most  frequently ruptured in apoplexy. 
The vertebral artery :  
Its branches include Posterior spinal artery which supply the  Dorsal 
1/3rd spinal cord .the Anterior spinal which supply the  Ventral 2/3rd spinal 
cord, the  Posterior inferior cerebellar Largest branch & supplies 
cerebellum, the Medullary branches which supply the   Medulla oblongata. 
The Basilar artery: Formed by union of vertebral arteries .Branches of  
basilar artery include Anterior inferior cerebellar (AICA) which supply the 
Inferior surface of cerebellum,the Labyrinthine (internal auditory) and 
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Internal ear,the  Pontine branch which supply the pons  the Superior 
cerebellar (SC) artery which spply Superior surface of cerebellum and 
anastomose with AICA and finally the  Posterior cerebral (PC) artey. 
Posterior cerebral  artery:  
Posterior cerebral is the Terminal branch  of basilar artery and its branches  
includes the  Cortical which supplies the inferior surface of cerebrum, 
occipital pole (visual cortex)  the  Central branches which supply the  
thalamus, 3rd ventricle, globus pallidus and the  Posterior choriodal arter 
which supply the choroid plexus of lateral ventricle, thalamus, fornix & 
tectum of midbrain. 
 
Circle of willis: 
Circle of Willis is an Arterial anastomosis  connecting vertebrobasilar &  
internal carotid systems Located at the base of interpeduncular fossa  
Branches Involved are  
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Figure 2 
 
1) Anterior communicating artery 
2)Anterior cerebral artery 
3)Internal carotid artery 
4)Posterior communicating artery 
5) Posterior cerebral artery. 
Importance of circle of Willis: It serves to equalise blood flow to various 
parts of brain and in  maintaining a constant supply of oxygen & glucose 
even when a  contributing artery is narrowed or in head movements . 
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Furnishes collateral circulation in cases of occlusion of one or  more of 
arteries contributing to circle. 
Venous drainage of the brain: 
Characteristic Features 
1) No valves 
2) Extremely thin walls 
3) Lack muscular tissue in tunica media 
4)Pierce arachnoid mater & inner layer of dura mater 
5)End in dural venous sinuses. 
 
                                       HISTORICAL ASPECTS 
Hippocrates, called stroke as apoplexy. Because of the fact patients dvelopd 
sudden inability to use the limbs. 
Jaecob vefer discovered that patients with sudden loss of consciousness died 
of internal hemorhage.later it was found out stroke was very similar to heart 
attack and was called brain attack . 
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Today there is enough information about stroke to public which has 
ultimatel increased awareness of timely recognition immediate medical 
attention. 
 
HOMOCYSTEINE : 
Homocysteine was first  discovered in 1932 by Butz and du Vigneaud.  As 
part of their studies into insulin, they heated an amino acid called 
"methionine" in sulfuric acid. They discovered that doing so changed 
methionine into a new amino acid which had similar chemical properties to 
cysteine. They suggested that  it should be called homocysteine. Later, du 
Vigneaud won the 1955 Nobel Prize in Chemistry, partly for his work on 
this 2 
Inborn Errors of Homocysteine Metabolism 
 Later Over the next few decades a  more clearer picture began to emerge of 
how the body breaks down or "metabolises" methionine. Homocysteine was 
identified as an one of the  important intermediate.  The discovery of 
patients with inherited or "inborn" errors of homocysteine metabolism gave 
a valuable insight into the roles of enzymes in this process. It was found that 
many of these enzymes needed B vitamins, including vitamins B12,  B6 and 
folate, to act as "cofactors" to help them work properly. 
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STROKE 
A stroke, defined as cerebrovascular accident (CVA), cerebrovascular 
insult (CVI), or colloquially brain attack  and it  is the loss of 
 brain functions due to a disturbance in the vascular  supply to the brain . 
This  may be either due to lack of blood flow or hemorrhage. 
Epidemiology: 
 Prevalence 
 One in every ten deaths is due to stroke and is surpassed only by CAD and 
malignancy.  
Stroke in india :  
India is facing an increase in stroke burden due to increased in mortality and 
morbidity due to stroke. Maximum case fatality was fond to be in Kolkata .  
Stroke rehabilitation is very poor in india. Rehabilitation centres are in 
private hospitals and in cities wher the bulk of the poor people cannot afford  
Government is organizing various programmes for non ommunicable 
diseases.  
Incidence 
 Within 5 years of a stroke, over half  of patients aged above  45 years will 
die: 52% of men and 56% of women. 
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BURDEN OF STROKE IN INDIA: 
                            The mortality due to stroke is decreasing in india but  .As 
life  expectancy is projected to increase in india but the epidemic of stroke is 
on the rise, India will face economic burden from this rising number of 
stroke patients. The economc burden of stroke in india has not been exactly 
accessed but it is estimated that india might have lost billions of rupees due 
to stroke  and more importantl indias GDP is estimated to fall owing to the 
burden of stroke,coronar diseases.3  
Some studies in the recent past ndicated the national percapita was a strong 
indicator of stroke outcome.  
 PATHOPHYSIOLOGY OF STROKE: 
The etiology of stroke involves two major mechanisms ischaemia and 
hemorhage. In ischemic stroke,which is a major contribtion in stroke 
etiology ther is decreaed blood and nutrient supply to the brain .brain suffers 
rapid damage because brain has got no glucose store and hence damge 
occurs very rapid .another small but next major contribtion of stroke is 
hemorrhage 4 . Intracerebral hemorrhage arising from deep penetrating 
vessels causes focal damge and mass effect of the surrounding tissues . 
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Focal Ischaemic Injury:  
A thrombus or  even an emboli  can obstruct flow in  particular vessel 
causes ischemia. But it is difficult to distinguish between the two causes.  
At tissue level stroke is a dynamic process and it evolves into stages .how 
the stroke progresses and how much amount of damage it has caused 
depends on its rate of progression .  
Collateral circulation:  
The presence of collateral circulation influences the outcome of stroke since 
abundant collaterals minimizes the adverse outcome of stroke. 
The Health of systemic circulation: 
Cerebral perfusion is autoregulated within a narrow range hence 
hypotension can compromise cerebral blood flow if it is very severe .  
Hematological factors:  
Presence of any hypercoagulable state influences the outcome of stroke in 
an adverse manner 
Temperature: increased bod temperatre has poor outcome 
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Glucose metabolism: hyper- hypoglycemia can have an adverse outcome 
on the size of infarct and recovery 
RISK FACTORS FOR STROKE: 
MODIFIABLE RISK FACTORS : 
Several very prevalent conditions potentiate the development of 
atherosclerosis. These conditions can affect almost all persons. The risk of 
stroke can be reduced if these factors are identified and controlled. Because 
these conditions are found in all segments of society, their treatment is 
crucial for an overall reduction in the incidence in stroke. Public health 
measures to screen and treat these risk factors can be applied to large 
segments of the general population. Because it is possible to detect some 
risk factors years before the development of symptomatic atherosclerosis, 
the effects of education to control risk factors will be greatest when applied 
to younger asymptomatic persons. Aggressive measures to control the risk 
factors do have an impact for example, some of the decline in stroke in 
Canada and United States is attributed to improved treatment of arterial 
hypertension. The presence of multiple risk factors greatly increases the 
likelihood of stroke or generalized atherosclerosis. Thus, all common risk 
factors should be sought and addressed. Control of risk factors is as 
important for asymptomatic patients in the general population as it is for 
persons with overt vascular disease. Although management after the 
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development of ischaemic symptoms focuses on medical or surgical 
measures to more directly prevent or treat the stroke, control of these risk 
factors to forestall the evolution of atherosclerosis remains a fundamental 
component of the overall care of these high-risk patients.5 
Arterial hypertension : 
 Arterial hypertension is the leading underlying, potentially treatable 
condition that promotes stroke.The prevalence of hypertension has not 
declined since the 1970s. Hypertension is calculated to be a factor in 70% of 
strokes and among survivors, it identifies a patient as having an increased 
risk of a second event. The risk of stroke increases 10-12 times if diastolic 
blood pressure is 105 mmHg in comparison to a normal diastolic blood 
pressure of approximately 76 mmHg.Overall, arterial hypertension increases 
the likelihood of stroke. The risk rises rapidly with higher levels of blood 
pressure. The impact of an increase in diastolic blood pressure is much 
greater in young adults than in the elderly. Although elevated diastolic 
blood pressure is a usual marker for hypertension, isolated systolic 
hypertension also predicts stroke in elderly persons. Isolated systolic 
hypertension also is correlated with increased thickness and plaque 
formation of the internal carotid artery. Both elevated diastolic and systolic 
blood pressures are associated with increased concentrations of hemoglobin,  
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Chronic hypertension promotes the development of both large-and medium 
caliber artery atherosclerosis and the lipohyalinosis of small penetrating 
arteries of the brain. The vascular endothelium is the central focus of the 
effects of hypertension that promotes turbulence at the site of an 
atherosclerotic plaque. Thus, hypertension can promote either major arterial 
occlusion and multilobar infarctions, or small artery occlusions that cause 
subcortical, lacunar infarctions. The relationship between arterial 
hypertension and small vessel occlusive disease is so strong that the 
diagnosis of a lacunar infarction is questioned if the patient does not have a 
history of  hypertension. Because hypertension leads to coronary artery 
disease, cardiomyopathy, and atrial fibrillation, it is an indirect risk factor 
for stroke secondary to cardioembolism. 
 Because hypertension is asymptomatic, it is unrecognized in a sizeable 
proportion of persons. In addition, many patients with arterial hypertension 
are not treated adequately.Reducing diastolic blood pressure by 
approximately 5 mmHg can reduce the incidence of and mortality from 
stroke by 42% and 30% respectively. In elderly patients, a drop of systolic 
blood pressure by approximately 11 mmHg can lead to a 30% decline in the 
frequency of stroke. A report from Asia concluded that a population-wide 
reduction of 3 mmHg in diastolic blood pressure could reduce the number of 
strokes by one-third. The optimal levels for blood pressure are 80-85  
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mmHg diastolic and 130-140 mmHg systolic. Options of treatments include 
changes in behavior, weight control, increased exercise, dietary 
modifications, and medications.: 
Diabetes mellitus : 
 Persons with either type I or type II diabetes mellitus have an increased 
susceptibility for large artery atherosclerosis and small artery occlusive 
disease.  
Diabetes mellitus also leads to renal or cardiac disease, which indirectly 
promote arterial hypertension and stroke. Diabetes also increase levels of 
fibrinogen and clotting factors, increase platelet aggregation, which in turn 
promotes arterial thrombosis. When compared to non-diabetic persons, the 
risk of stroke increases in proportion to increases in levels of blood glucose 
especially in young adults. Diabetic patients with stroke are typically 
younger than patients with stroke who do not have diabetes mellitus. The 
severity of and mortality after stroke also are higher among patients with 
diabetes. A markedly elevated level of blood glucose can cause neurological 
deficits associated with alternations in consciousness. Usually focal signs 
are not prominent among patients with hyperglycemia. Conversely, 
hypoglycemia is more common than hyperglycemia in mimicking the 
symptoms and signs of acute ischaemic stroke.  
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Prolonged periods of hypoglycemia can lead to neurological sequelae, 
including cognitive impairments. Thus, prompt treatment of a low serum 
glucose level is a critical component of urgent care in cases of suspected 
stroke. 
Elevated blood lipids  
 In the past, the role of elevated blood lipids in the development of 
ischaemic cerebrovascular disease was unclear largely because advancing 
age lessened the impact of the condition as a predisposing factor for stroke. 
In addition, sizeable proportions of strokes that are hemorrhagic or that are 
not secondary to atherosclerosis were included in the analyses. In fact, the 
proper analysis is to study the relationship of hyperlipidemia to stroke 
secondary to atherosclerosis. This analysis could include or exclude 
cardioembolic strokes secondary to myocardial infarction or ischaemic heart 
disease.The incidence of coronary artery disease and atherosclerosis of 
major intracranial or extracranial arteries increases with rising levels of 
serum cholesterol 6. Recent data show that hypercholesterolemia is a key 
risk factor for ischaemic stroke, especially in men under the age of 60. 
Hyperlipidemia causes a modest increase in risk of stroke in persons older 
than 62. Some of the risk may be indirect, due to the potent effects of 
hyperlipidemia on coronary artery disease, leading to myocardial infarction 
and cardioembolism. The desired levels of total cholesterol, LDL 
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cholesterol, and HDL cholesterol are <200 mg/dL (5.20 mmol/L), <130 
mg/dL (3.36 mmol/L), and >35 mg/dL (0.9 mmol/L), respectively. The risk 
of stroke is lowest among men with the highest HDL cholesterol levels. 
Elevated serum apolipoprotein A1 and B concentrations are found in young 
adults with stroke. The significance of elevated apolipoproteins and stroke is 
uncertain. The influence of hypertriglyceridemia has not been determined 
on the course of atherosclerosis. 
Obesity : 
 Overweight men have approximately twice the risk of stroke than thin 
men.However, obesity is not identified as a primary risk factor for stroke, 
though an elevated body weight predisposes to vascular disease via its 
aggravation of arterial hypertension, diabetes mellitus, and heart disease. 
The risk from obesity appears to be separate from the risk associated with 
elevated serum cholesterol levels. Thus, obesity should be considered as a 
contributing factor for stroke. Weight reduction remains a component of 
general public health activities to lessen the likelihood of ischaemic stroke. 
Physical Inactivity  
 Although physical inactivity is a well known risk factor for coronary artery 
disease, its relationship to ischaemic stroke is not as apparent.Gillum et al 
found the strongest relationship between a high risk of stroke and a low 
level of exercise among younger persons. In addition, exercise decreases the 
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risk of ischaemic stroke by reducing platelet aggregation and increasing 
insulin utilization. 
Hyperhomocystinemia  
Homocysteine has been found to be a potential  many vascular 
catastrophy.it is found in ; folate, pyridoxine, and vitamin B12.increased 
homocysteine level has been found to be a risk factor for stroke  , aortic 
disease, ischaemic heart disease. It may cause endothelial damage , smooth 
muscle proliferation, ECM changes , and lipoprotein oxidation in the arterial 
wall. Homocysteine increases the rate of atherosclerosis and may potentiate 
the other risk factors like smoking and alcohol in causing vascular           
damage 7 8 9 
Smoking damages the endothelium, accelerates atherosclerosis, and 
increases the immune response and cholesterol concentration in arterial 
walls and decreases endothelial function. It also increases hemoglobin, 
serum fibrinogen, platelet aggregation, LDL cholesterol, and the hematocrit 
as it decreases HDL cholesterol levels. Smoking promotes the progression 
of atherosclerotic plaques of the carotid artery. Similar findings are noted in 
studying the coronary arteries and the thoracic aorta. Smoking can lead to 
stroke by aggravating coronary artery disease. Advanced intracranial 
occlusive disease, causing moyamoya syndrome, also has been associated 
with smoking, particularly in young women using oral contraceptives. 
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Although cigarette smoking is most commonly implicated, the use of cigars, 
pipes, or chewing tobacco also probably increases the risk of 
atherosclerosis. Chewing tobacco also can be a risk factor for stroke.  
Alcohol Use : 
 Minimal alcohol drinking lessens the risk of vascular events , possibly by 
increasing the concentration of HDL cholesterol. The definition of mild-to-
moderate consumption of alcohol is amorphous but probably is less than 
100 gm/week. 
Drinking a glass of wine is not an antidote to other dietary indiscretions. 
Alcohol abuse and acute alcohol intoxication can lead to ischaemic stroke 
due to alcohol induced cardiomyopathy, changes in viscosity, and 
disturbances in coagulation and fibrinolytic factors. heavy alcohol  drinking 
on weekends and holidays are  related to high risk of  vascular events in 
young persons. Young adults and adolescents should be warned about the 
increased likelihood of stroke that can occur with heavy alcohol 
consumption. 
Drug Abuse : 
 The role of drug abuse in the etiology of stroke needs additional definition. 
Some of the perceived or real increase of stroke in young adults might be 
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secondary to drug abuse. Abuse of drugs, in particular cocaine and 
stimulants, can cause stroke.  
Persons abusing parenterally administered drugs also have a risk for 
infective endocarditis that leads to embolism to the brain. 
Post-menopausal use of estrogens  
Information is limited about the influence of the use of estrogens or estrogen 
/ progesterone medications on the rate of ischaemic stroke in post-
menopausal women. At present, the evidence suggests that post-menopausal 
estrogen supplementation may be helpful. Conversely, there is no evidence 
that post-menopausal use of estrogens increases the likelihood of ischaemic 
stroke. 
Oral contraceptives  
Shortly after the introduction of oral contraceptives, epidemiological studies 
noted that these medications increased the risk of stroke in young women. 
Some young women using oral contraceptives may have an increased risk 
for stroke. The risks seem to be lower in younger women (under age 35) and 
in those who do not smoke or have hypertension. Use of oral contraceptives 
has been associated with advanced intracranial occlusive disease 
(moyamoya syndrome). Recent studies have suggested that oral 
contraceptives may be a contributing factor for stroke but that their impact 
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may be marginal. At present, there is no evidence that oral contraceptive use 
is a major risk factor for stroke in young women. 
Migraine:  
Various studies been done between  migraine and ischaemic stroke and it 
was found that migrane increased  stroke incidenceespeciall in OCP users. 
NON MODIFIABLE RISK FACTORS: 
Age  
 Stroke can affect a person at any age. Still, advancing age is the single most 
important factor that predicts an increased likelihood of ischaemic stroke. 
Risks increase rapidly after the age of 55 in both men and women of all 
ethnic groups. The risks of stroke approximately double with every 10-year 
increase in age.A person’s age also influences prognosis. Elderly patients 
die more often and recover less from stroke than do persons under the age of 
65. 
Sex  
Stroke is an important cause of death and disability in men and women of 
all  age and ethnic groups. In almost all age groups, ischaemic stroke is 
more common in men than in women except for a slightly higher risk of 
stroke among women ages 15-30 because cerebrovascular events occur as a 
complication of pregnancy and the puerperium. 
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Ethnicity and Geography  
 Stroke affects all ethnic groups and races in the world. No geographic 
region of the world is protected from ischaemic stroke. 
 Epidemiological data are sketchy for estimating accurate rates in most of 
the Middle East, Africa, South Asia, or Latin America. The types of stroke 
also vary among ethnic groups; for example, lacunar infarctions are more 
common in Chinese than other populations. An association of arterial 
hypertension and ischaemic stroke is stronger in eastern Asian populations, 
where cholesterol concentrations are very low. Rate are higher in Hispanic 
Americans than in non-Hispanic white Americans younger than 65, the 
incidence of stroke is similar in the two groups in older persons. Stroke 
recurrences are more frequent in African American and Hispanic Americans 
than among whites.  Further research is needed to understand the differences 
in the rates of stroke, mortality, and risk of recurrences in Americans of 
different ethnic groups. Some of the differences may be secondary to 
differences in the prevalence of important risk factors. 
 The ethnicity of a patient remains important in the evaluation of the risk for  
stroke. It also is consequential in the determination of the cause of 
ischaemic stroke and for treatment plans.. A person’s marital status is 
important and regardless of age, married persons have a lower risk of stroke 
than do single people.  
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Living alone also affects an individual’s likelihood of reaching medical 
attention quickly after stroke and his or her outcomes after rehabilitation. 
Family history of vascular disease  Ischaemic stroke results from a number 
of inherited disorders of coagulation or of genetic disorders that predispose 
to arterial disease. In addition, hereditary disorders, such as diseases of lipid 
metabolism, can promote premature development of atherosclerosis. 
Familial predisposition to diabetes mellitus or migraine also may play a role 
in the development of stroke. A family history of deep vein thrombosis, 
pulmonary embolism, or spontaneous abortions points to the possibility of a 
hereditary prothrombotic state. 
Ischaemic stroke also appears to peak in the first hours after awakening in 
the morning. This rise may be secondary to changes in blood pressure or 
coagulation. These associations and potential responses require further 
clarification. 
NOVEL RISK FACTORS: 
1.Excess homocysteine in blood High levels may be associated with an 
increase in cardiovascular risk. 
2.Inflammation :Several inflammatory markers are associated with 
increased cardiovascular risk, e.g. elevated C-reactive protein (CRP). 
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3.Abnormal blood coagulation Elevated blood levels of fibrinogen and other 
markers of blood clotting increase the risk of cardiovascular complications. 
TYPES OF STROKE: 
ISCHAEMIC STROKE : 
Acute ischaemic stroke involves a rapidly evolving, complex series of 
events, which include intravascular, endothelial, neuronal, glial, and 
inflammatory changes that either progress to cell death or resolve with the 
survival of a functioning neuron. Whereas some cells may die immediately, 
other dysfunctional neurons may survive if interventions to improve 
perfusion and maintain cell function are prescribed rapidly.  
Research advances are providing new insights into a number of cellular 
phenomena that  develop during ischaemia. 
The theory of the ischaemic penumbra forms a critical underpinning for the 
current approach to acute ischaemic stroke. Following arterial occlusion, a 
core of brain may have an irreversible neuronal injury because of profound 
hypoperfusion and cell dysfunction. This core of brain tissue rapidly 
becomes necrotic and unsalvageable. Although the core of completely 
ischaemic tissue has markedly reduced cerebral blood flow and metabolic 
activity adjacent, partially ischaemic tissue (penumbra) has borderline levels 
of blood flow and metabolic function. Fortunately, the area of dysfunctional 
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but not dead brain tissue may be relatively large in the setting of acute 
ischaemic stroke. Potentially, the majority of the affected area of the brain 
may encompass the penumbra. Dysfunctional borderline areas have the 
potential for recovery with restitution of adequate perfusion or institution of 
measures to halt the metabolic consequences of ischaemia.  
TYPES OF ISCHAEMIC EVENTS  
 Ischaemic cerebrovacular disease can be divided into subgroups based on 
the area of brain involved, the time course of the event, and the severity of 
neurological impairment. 
1)Time Course  
 -Transient ischaemic attack  
- Amaurosis fugax  
-Cerebral infarction with transient symptoms  
-Reversible and partially reversible ischaemic neurological deficits  
-Minor ischaemic stroke  
-Acute ischaemic stroke  
-Completed stroke  
-Vascular dementia  
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2.Area of Brain-Vascular infrastructure  
-Vertebral artery  
 Posterior inferior cerebellar artery  
-Basilar artery : 
 Anterior inferior cerebellar artery  
 Internal auditory artery  
 Superior cerebellar artery  
-Posterior cerebral artery  
-Internal carotid artery : 
-Anterior cerebral artery  
-Middle cerebral artery  
-Cortical branch arteries  
-Watershed (borderzone) infarction  
-Vascular centrencephalon  
-Lacunar infarction 10 
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TIA: 
The term transient ischaemic attack (TIA) describes a brief episode of 
transient focal neurological impairment that is of vascular origin. The 
original definition of TIA included a time limit on neurological symptoms 
that could extend to 24 hours, but this time window is far too long. Episodes 
of TIA usually last only a few minutes and almost all resolve within 20 
minutes. In fact, most patients whose neurological symptoms persist more 
than 1 hour have a hypodense lesion found on  
CT scan of the brain. 
 Rather than being a risk factor for stroke, a TIA is a warning sign and a  
marker of instability for the underlying disease causing a stroke. The 
occurrence of a TIA should lead to prompt evaluation and initiation of 
therapies to prevent stroke.  
An episode of painless, transient monocular visual loss, or amaurosis fugax 
(transient monocular blindness), predicts ischaemic stroke and is a warning 
for either retinal or cerebral ischemia. Its importance as an omen for stroke 
derives from the common blood supply (internal carotid artery) to the eye 
and the ipsilateral cerebral hemisphere. Cerebral infarction with transient 
symptoms (CITS) is made when a patient clinically has a TIA but a 
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subsequent brain imaging study demonstrates an infarction. In most cases, 
these patients will have symptoms that last 1 hour or longer. 11 
 Terms such as reversible ischaemic neurological deficit (RIND) and 
partially reversible ischaemic neurological deficit (PRIND) previously were 
applied to events that lasted longer than 24 hours or cases in which the 
neurological signs did not completely disappear 12. These terms have 
outlived their usefulness and have been supplanted by the term minor 
ischaemic stroke. A clinically silent infarction also may be found on brain 
imaging. These strokes can be detected in up to  20% of patients who are 
seen with signs of an acute stroke. First few hours or days after onset, the 
term acute (hyperacute) ischaemic stroke has been coined. The term brain 
attack is being used to describe stroke to the public.  
The upper time limit for acute ischaemic stroke has not been defined, but 24 
hours probably is the maximal duration. A better time limit might be the 
first 3-12 hours. The diagnosis of stroke in evolution (progression stroke) is 
made when a patient’s neurological signs are worsening. A patient whose 
neurological signs persist for at least 24 hours is considered to have had a 
completed stroke. Whereas a single stroke causes focal neurological 
impairments that reflects the area of brain injury, the effects of recurrent 
strokes are more pervasive. In particular, resulting declines in cognition and 
intellect lead to vascular dementia.  
 
 
30 
 
Vascular dementia can be the result of multiple, bilateral infarctions, 
particularly in the basal ganglia. Stepwise mental deterioration occurring in 
conjunction with other neurological signs is the hallmark for a variety of 
vascular dementia called multi-infarct dementia. 
ETIOLOGY: 
The causes of cerebral ischaemia and infarction are: 
1)Arterial wall disorders 
 Atherothoromboembolism  
  Intracranial small vessel disease (lipohyalinosis, arteriolosclerosis,  
microatheroma)  
  Trauma  
  Dissection  
  Fibromuscular dysplasia  
  Congenital arterial anomalies  
 Moyamoya syndrome  
  Embolism from arterial aneurysms  
 Inflammatory vascular diseases  
 Antiphospholipid antibody syndrome  
  Primary systemic vasculitis  
  Rheumatoid disease  
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  Sjogren’s syndrome  
  Behcet’s disease  
  Relapsing polychondritis  
  Progressive systemic sclerosis  
 Sarcoid angiitis  
  Isolated angiitis of the central nervous system  
  Malignant atropic papulosis  
 Acute posterior multifocal placoid pigment epitheliopathy  
  Buerger’s disease  
  Leukoaraiosis  
  Irradiation  
 Infections  
Embolism from the heart  
 Paradoxical embolism from the venous system  
  Atrial septal defect  
 Ventricular septal defect  
 Patent foramen ovale  
  Pulmonary arteriovenous fistula  
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Left atrium  
 Sino atrial disease  
  Myxoma  
  Inter-atrial septal aneurysm  
 Mitral valve  
 Rheumatic stenosis or regurgitation  
  Infective endocarditis  
  Non-bacterial thrombotic (marantic) endocarditis  
  Prosthetic valve  
  Mitral annulus calcification  
 Mitral leaflet prolapse  
 Libman-Sacks endocarditis  
  Papillary fibroelastoma  
 Left ventricular mural thrombus  
 Acute myocardial infarction  
 Left ventricular aneurysm  
  Cardiomyopathy  
  Myxoma  
 Blunt chest injury  
  Mechanical artifical heart  
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 Aortic valve  
 Rheumatic stenosis or regurgitation  
  Infective endocarditis  
  Non-bacterial thrombotic (marantic) endocarditis  
  Prosthetic valve  
  Calcification and / or sclerosis  
  Syphilis  
  Congenital cardiac disorders  
 Others  
 Primary oxalosis  
  Hydatid cyst  
2) Haematological disorders : 
 Polycythemia  
  Essential thrombocythaemia  
 Sickle-cell disease / trait and other haemoglobinopathies  
 Iron deficiency anaemia  
  Paraproteinaemias  
  Paroxysmal nocturmal haemoglobinuria  
 Thrombotic thrombocytopenic purpura  
 Disseminated intravascular coagulation  
 Thrombophilias and other causes of ‘hypercoagulability’  
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Miscellaneous conditions  
 Pregnancy / puerperium  
 Oral contraceptives and other female sex hormones  
  Drug abuse  
  Cancer  
  Perioperative  
 Migraine  
  Inflammatory bowel disease  
  Homocystinaemia  
  Fabry’s disease  
  Mitochondrial cytopathy  
  Hypoglycemia  
  Fibrocartilaginous embolism  
  Snake bite  
  Fat embolism  
  Epidermal naevus syndrome  
  Susac’s syndrome  
 Nephrotic syndrome  
  CADASIL (Cerebral Autosomal dominant arteriopathy with 
subcortical 
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CLINICAL FEATURES OF ISCHAEMI STROKE 
MCA STROKE( middle cerebral artery stroke): 
Focal symptomes of infarction in middle cerebral  artery :  
1. Motor disorders – Hemiplegia  
2. Sensory disorders - Hemianesthesia  
3. Gaze paresis 
4. Visual disorders – Hemianopia 
The lesion of the left MCA: 
1. Aphasia 
2. Alexia 
3. Acalculia  
The lesion of the right MCA.  
Apracto – agnostic syndrome 
•   Anozognosia  
•   Astereognosis  
•   Autotopognosia  
•   Apraxia  
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Focal symptomes of infarction in anterior cerebral  artery : 
• Spastic hemiparesis with the prevalence in proximal part of upper 
extremity and distal part of lower extremity 
• Symptoms of oral automatism  
• Psychiatric disorders – frontal mental disorders 
• Dysphagia  
• Dysphonia  
• Astasia, abasia  
• Motor aphasia 
• Retention of urine  13 
Focal symptomes of infarction in posterior cerebral  artery : 
• Hemianopsia  
• Visual agnosia  
• Hemianesthesia  
• Hyperpathia  
• Desorientation in space and time 14 
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Focal symptoms of infarction in vertebral  artery:  
Atherosclerosis has a predilection for the origin and distal segments of these 
vessels, predictably atheromatous disease at each site produces is own 
clinical syndrome. Atherothrombotic lesion have a predilection for first and 
fourth segments of the vertebral arteries but narrowing of first division 
rarely produce stroke because of collaterals. Fourth segment occlusion 
produces Wallenburg’s syndrome (lateral medullary syndrome) 15. 
In case of extracranial lesion: 
• systemic dizziness 
• Hearing disorders 
• Visual disorders 
• eye movements disorders 
• Vestibular and equilibrium disorders  
• paresis with sensory disturbances in extremities 
• some patients have “ drop- attacks “.  
Focal symptoms of infarction in basilar artery: 
• loss of consciousness 
• eye movements disorders 
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• pseudobulbar syndrome 16 
Anterior choroidal artery occlusion presents with :  
 The complete clinical syndrome of anterior choroidal artery 
occlusion consists of :  
• Contralateral hemiplegia.  
• Contralateral hemianesthesia  
• Homonymous hemianopia 17 
However, because this territory is also supplied by penetrating vessels 
of proximal MCA and the posterior communicating and posterior choroidal 
arteries,  minimal deficits may occur and patient frequently recovers 
completely. 
ICA occlusion presents with :  
The clinical picture of ICA occlusion varies can be asymptomatic but 
usually presents with deficit similar to MCA occlusion. Transient 
monocular blindness occurs   in about 25% patients.  
 Patients with fetal posterior cerebral artery may present with 
symptoms referable to peripheral territory. Carotid artery bruit is an 
important sign and a high  pitched prolonged carotid bruit fading into 
diastole is often associated with highly stenotic lesions 18. 
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Anterior inferior cerebellar artery presents with :  
Ipsilateral deafness, facial weakness, vertigo, nausea, vomiting, 
nystagmus, tinnitus, cerebellar ataxia, Horners syndrome, paresis of 
conjugate gaze. Contralateral loss of pain and temperature 19.  
 Important syndromes of posterior circulation are:  
• Lateral medullary syndrome  
• Medial medullary syndrome  
• Ventral / dorsal syndrome. These can be present in complete or 
partial form or  in combination.  Among these lateral medullary 
syndrome is more common. 
Lateral medullary syndrome  
Same side :  
• Pain, numbness, impaired sensation over half the face.  
• Dysphagia, hoarseness, paralysis of palate.  
Opposite side :  
• Impaired pain and thermal sensation 
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Medial medullary syndrome : 
 On the side of lesion – Paralysis with atrophy of half of the tongue.  
On side opposite lesion – Paralysis of arm and leg sparing face, 
impaired tactile and proprioceptive sensation over half the body 20. 
HEMORRHAGIC STROKE: 
This is a common cause of stroke and could be de to ruptured av 
malformation, aneurysmal rupture se of anticoagulant or thrombolytics  
cerebral amyloidosis. 
Primary (Hypertensive) Intracerebral Hemorrhage 
In order of frequency the cerebral sites are (1) the putamen ,internal capsule 
(50percent); (2) temporal, parietal, or frontal lobes ; (3) the thalamus; (4) a 
cerebellar hemisphere; and (5)the pons. The vessel involved is usually a 
penetrating artery that originates from a larger trunk vessel. About 2 percent 
of primary hemorrhages are multiple.  
However, a hemorrhage of this type almost never ruptures through the 
cerebral cortex. When the hemorrhage is small and located at a distance 
from the ventricles, the CSF may remain clear even on repeated 
examinations. In the first hours and days following the hemorrhage, a 
limited amount of edema accumulates around the clot and adds to the mass 
effect. Hydrocephalus may occur as a result of bleeding into the ventricular 
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system or from compression of the third ventricle. Extravasated blood 
undergoes a predictable series of changes 21. 
Within a few days, hemoglobin products, mainly hemosiderin and 
hematoidin, begin to appear Hemorrhages may be described as massive, 
moderate, small, slit, and petechial. Massive refers to hemorrhages several 
centimeters in diameter; small applies to those 1 to 2 cm in diameter and 
less than 20 mL in volume; a moderate-sized hemorrhage, of course, falls 
between these two, both in diameter and in volume.  
 
Pathogenesis The hypertensive vascular lesion that leads to arterial 
rupture in some cases appears to arise from an arterial wall altered by the 
effects of hypertension, i.e., the change referred to in a preceding section as 
segmental lipohyalinosis and the false aneurysm (microaneurysm) of 
Charcot-Bouchard. Ross Russell has affirmed the relationship of these 
microaneurysms to hypertension and hypertensive hemorrhage and their 
frequent localization on penetrating small arteries and arterioles of the basal 
ganglia, thalamus, pons, and subcortical white matter. However, in the few 
hemorrhages examined in serial sections by our colleague C. M.Fisher, the 
bleeding could not be traced to Charcot-Bouchard aneurysms. 
Takebayashi and coworkers, in an electron microscopic study, found breaks 
in the elastic lamina at multiple sites, almost always at bifurcations of the 
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small vessels. Possibly these represent sites of secondary rupture from 
tearing of small vessels by the expanding hematoma 22. 
Clinical Picture brain hemorrhage is  a very sudden also from ancient times 
surrounded by “an aura of mystery and inevitability.” It has been given its 
own name, “apoplexy.” The prototype is an obese, plethoric, hypertensive 
male who, while sane and sound, falls senseless to the ground—impervious 
to shouts, shaking, and pinching— breathes stertorously, and dies in a few 
hours. A massive blood clot escapes from the brain as it is removed 
postmortem. 
Several general features of intracerebral hemorrhage should be emphasized. 
Acute reactive hypertension, far exceeding the patient’s chronic 
hypertensive level, is a feature that should always suggest hemorrhage; it is 
seen with moderate and large clots situated in deep regions. Vomiting at the 
onset of intracerebral hemorrhage occurs much more frequently than with 
infarction andshould always suggest bleeding as the cause of an acute 
hemiparesis. 
Severe headache is generally considered to be an accompaniment of 
intracerebral hemorrhage and in many cases it is, but inalmost 50 percent of 
our cases headache has been absent or mild in degree. Nuchal rigidity is 
found frequently; but again, it is so often absent or mild that failure to find it 
should does not eliminate the diagnosis. (Stiffness of the neck 
characteristically disappears as coma deepens). It should also be noted that 
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the patient is often alert and responding accurately when first seen. This can 
be true even when the CSF is grossly bloody; thus the adage that 
hemorrhage into the ventricular system always precipitates coma is quite 
incorrect. Only if bleeding into the ventricles is massive will coma result.  
           The fundi often show hypertensive changes in the arterioles. Rarely, 
white-centered retinal hemorrhages (Roth spots) or fresh preretinal 
(subhyaloid) hemorrhages occur; the latter are much more common with 
ruptured aneurysm, arteriovenous malformation, or severe trauma. 
Headache, acute hypertension, and  vomiting with a focal neurologic deficit 
are therefore the cardinal features and serve most dependably to distinguish 
hemorrhage from ischemic stroke. 
Hemorrhages that complicate the administration of anticoagulants, like 
those from some vascular malformations, may evolve at a slower pace. 
Usually there are no warnings or prodromal symptoms; headache, dizziness, 
epistaxis, orother symptoms do not occur with any consistency. There is no 
age predilection except that the average age of occurrence is lower than in 
thrombotic infarction, and neither sex is more disposed. 
The incidence of hypertensive cerebral hemorrhage is higher in African 
Americans than in whites and seems recently to have been reported with 
increasing frequency in Japanese. In the majority of cases, the hemorrhage 
has its onset while the patient is up and active; onset during sleep is a rarity.  
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There has long been a notion that acute hypertension precipitates the 
hemorrhage in some cases. This is based on the occurrence of apoplexy at 
moments of extreme fright or anger or intense excitement, presumably as 
the blood pressure rises abruptly beyond its chronically elevated level. The 
same has been described in relation to taking sympathomimetic medications 
such as phenylpropanolamine (Kernan et al), ephedra, or cocaine and to 
numerous other similar circumstances. However, in fully 90 percent of 
instances, the hemorrhage occurs when the patient is calm and unstressed 
(Caplan, 1993). The level of blood pressure rises early in the course of the 
hemorrhage, but the preceding chronic hypertension is usually of the 
“essential” type. Other causes of hypertension must always be considered—
renal disease, renal artery stenosis,  toxemia of pregnancy, 
pheochromocytoma, aldosteronism, adrenocorticotropic hormone or 
corticosteroid excess and, of course, sympathetically active drugs. 
There is ordinarily only one episode of hypertensive hemorrhage; recurrent 
bleeding from the same site, as happens with saccular aneurysm and 
arteriovenous malformation, is infrequent. However, it is now recognized by 
serial CT scanning that in many instances, as the patient’s condition 
worsens over a few hours, there may be slight enlargement of the 
hematoma. In the series of Brott and colleagues, one-quarter of hematomas 
were found to have enlarged in the first hour and another 12 percent in the 
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first day. Blood that has extravasated into cerebral tissue is absorbed slowly, 
over a period of months, during which time symptoms and signs recede. 
Hence the neurologic deficit is never transitory in intracerebral hemorrhage, 
as it so often is in embolism; for the same reason, one does not expect rapid 
improvement in the neurologic deficit from one examination to another. 
 
CORTICAL VENOUS THROMBOSIS: 
Cerebral venous thrombosis, including venous sinus thrombosis and cortical 
vein thrombosis, is  a relatively rare cause of stroke. The annual incidence is 
estimated to be 3- 7 cases per million  people representing <1% of all 
strokes It is more common among young women and  children. Though it 
can cause devastating injury to the brain, most patients have a good  
prognosis if it is recognized and treated early. 
 
PATHOPHYSIOLOGY 
Multiple causative  factors are associated with the development of cerebral 
venous thrombosis . Thrombosis develops from common pathways of 
hypercoagulability,  hemoconcentration, direct injury or inflammation of the 
vessel, venous stasis, and obstruction of flow. Two specific mechanisms are 
responsible for the etiology of injury. Thrombosis  in the cortical veins 
causes localized vasogenic edema, venous infarction with cytotoxic edema, 
and hemorrhage. Thrombosis of the large venous sinuses obstructs venous 
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drainage leading to impaired CSF absorption through the arachnoid villi and 
intracranial hypertension withouthydrocephalus 23. 
 
CLINICAL FEATURES 
The onset of symptoms can be acute, subacute or chronic. Headache is the 
most common  presenting symptom of cerebral venous thrombosis, present 
in nearly 90% of patients. Other  common presenting symptoms include 
focal or generalized seizure (40%), focal motor  weakness (37%), 
encephalopathy or change in mental status (22%), vision loss (13%), 
diplopia (13%), stupor or coma (13%). The particular constellation of 
symptoms and exam findings  reflects the extent to which the cortical veins 
(seizure and focal neurologic symptoms) and large venous sinuses (elevated 
intracranial pressure, bi-hemispheric symptoms) are involved. 
Papilledema may be present in 25-30% of patients. Thrombosis of the deep 
cerebral veins (vein of Galen, straight sinus, internal cerebral veins) can 
produce a spectrum from mild cognitive  disturbances to coma. Thrombosis 
of the cavernous sinus produces a characteristic syndrome  of orbital pain, 
proptosis, chemosis and variable dysfunction of cranial nerves III, IV, V, 
and VI 24. 
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YOUNG STROKE 
Cerebrovascular atherosclerosis was assumed to be  the cause of Cerebral 
nfarction  if artiography revealed any type or  degree of plaque in the 
appropriate proximal arteries  and if other probable causes were absent. 
Although arteriographically visible, asymptomatic cerebrovascular 
atherosclerosis is relatively uncommon in people under 40, it is possible that 
some patients had asymptomatic plaques and Cerebral infarction  of other  
etiology 25. 
 
Incidence of Young Stroke 
Below age group of thirty five , rates are less than ten in hundred thousand  
.and in the age group  33 to 42 , it is about twent two to forty five in  
hundred thousand patients 26.  
 
ETIOLOGY OF YOUNG STROKE: 
Majority of strokes are due to  SAH and ICH  in young   people           
(40–55%) on comparing to the whole poplation of stroke (15–20%), 
cerebral infarction is very common. High incidence of cerebral infarction 
was  found in young people with usual vascular risk factors is seen, 
especially in  countries which are developing  due to more population is 
involved in smoking  and industrialization. However, etiology of stroke in 
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young people differ in frequency compared to those observed in the elderly. 
This is especially  true in adult patients who are below   30 years of age 27. 
 
 CARDIOEMBOLIC STROKE 
Mitral valve disease, which is an etiology for cardioembolic stroke in 
young people , is more often seen in patient poplation having rheumatic 
heart disease as an etiology 28. 
 
Patent Foramen Ovale (PFO) and Stroke : 
A relation  which  occurs between  patent foramen ovale  and youn stoke 
remains a confused topic . PFO is seen among  young patients who are 
diagnosed with cryptogenic stroke 45 .  
 
Thrombophilia and Stroke:  Apart from APLAS, thrombophilia  itself is 
not an etological risk factor for stroke , and there are few evidences showing 
that  mutation in  prothrombin gene, in particular, increases the risk of 
ischaemic stroke in patients with PFO 46.  
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Migraine and Stroke 
Studies show  migraine,  specifically   migraine with auera, there is 
more chances of  stroke in women who are  under 45 years of age . The 
mechanism still not clear.  
 
Stroke in the Puerperium 
Incidence  is around 4 to 210 in 100 000 deliveries , causing to atleast 
12% of maternity  deaths.  Cerebral haemorrhage was found to be an 
important etiology  of death in patients with eclampsia but  some studies 
shows preeclampsia also there is ischaemic stroke are. Subarachnoid 
haemorrhage is  3rd important etiology for  for nonobstetric-related maternal 
death,  which is most often de to aneurysmal rupture 29. 
 
Antiphospholipid Antibody Syndrome 
Ischaemic stroke  is found in antiphospholipid  syndrome  according 
to a large cohort study . presence of lupus anticoagulant  has an increased 
risk  compared to other antiphospholipid antibodies is still unclear . links 
have been found between young  ischaemic stroke , lupus  protein .both of 
these were assoiated .anticardiolipin  antibodies 30.  
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Nonatherosclerotic Vasculopathies 
The most common cause for non atherosclerotic vasculopathy is 
cervical artery dissection. Next is vasulitis arising as a result of infection 
,next are moyomoya which is seen more in asian population and the migrane 
bt the contribute less than 1 percent. These patients show geographical and 
sometime ethical variation like moyamoya takayasu was also fond to be 
more common in asian population.  
Vasulitis due to infectious cause is found more in young stroke 
patients of asian origin .  with the exclusion of cerebral angitis systemic 
vasculitis only rarel causes stroke. But concurrent atherosclerotic disease 
may increase the stroke predisposition in such patients  . 
 
Extracranial ArterialDissection: 
Cervical artey dissection is a significant cause of stroke in middle 
aged men but the exact etiolog remains unrecognised.trauma, infections and 
even migrane have been linked to CAD but there is lack of strong evidence 
to support it.  
 
Haemorrhagic Stroke 
Many studies tell that  subarachnoid and intracranial haemorrhage  
are the etiological factors in around 25–55% of stroke patients who are 
within the age of 45 with incidence around 2 to 5 . The usual link which is 
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between hypertension and intracranial haemorrhage may be the reason why 
ther is more cases of intracranial haemorrhage  seen in  young blacks of 
America, with one study showing there is more  cases of hypertensive 
intracranial haemorrhage  seen in young blacks. A reasonably more cases of 
intracranial haemorrhage was seen in  in young  Nigerians 47 
 
HYPERHOMOCYSTEINEMIA:  
Man observational studies have been done to establish a positive 
correleation between serum homocysteine and stroke and the results had a 
positive relation between the two. 
Homocsteine levels has to bemeasured in any stroke patients of 
younger age group and in whom definite etiolog could not be established . 
They are supplemented with folate ,vitamin B12 and vitamin B6. 
 
CRYPTOGENIC STROKE 
In about 30% of patients, the cause of stroke cannot be  identiﬁed 
despite the detailed and comprehensive  aetiological work up described in 
this Review. Some of  these patients might have classic vascular risk 
factors, but  they do not show evidence of large atherosclerotic or 
smallvessel arterial disease. Minor atherosclerotic lesions might  be missed 
by current diagnostic and imaging techniques.  
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A frequent mistake is the diagnosis of cryptogenic stroke  in patients with 
incomplete or delayed aetiological  investigation. This misdiagnosis is of 
particular importance in dissection, which can resolve quickly, and in  
intracardiac thrombus, which can either resolve or  fragment and embolise. 
Results of some biological  diagnostic tests (eg, antiphospholipid antibodies 
for antiphospholipid syndrome or platelet count for  thrombocythaemia) can 
ﬂ uctuate, and therefore repeated  assessment is needed. Repeated or 
extended Holter  monitoring might be necessary if paroxysmal arrhythmias  
are suspected. Repeated angiography might also be  necessary to distinguish 
between reversible cerebral vasoconstriction syndrome, in which the various 
segmental  arterial narrowings are reversible, and vasculitis,  
atherosclerosis, or other vasculopathies of intracranial arteries, in which the 
narrowings persist or even progress 31. 
 
NEW RISK FACTORS FOR STROKE: 
Inherited Susceptibility 
A history of stroke in family is  one of the  risks for stroke of ischaemic 
etiology, but the pathogenesis is very unclear . Inheritence of risk to 
ischemic stroke  can be  due to direct  presence of a particular single  gene, 
various interactions of a gene with environmental factors, or an combined 
effect of several genes (a gene-dose effect), or mutual co effects of  various 
genes. A classic mendelian type of inheritance of single-gene disorder is 
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very uncommon , causing for less than one percent of cases of ischemic 
stroke. 
 
Inflammatory Markers: 
Leukocyte and Monocyte Counts 
 Monocyte count  was found to be an predictor of  future carotid artery 
atherosclerosis in patients without any carotid atherosclerosis. 
 
High-Sensitivity C-Reactive Protein 
Man studies have demonstrate that highly-sensitive C-reactive protein is a 
predictor of stroke, MI, and vascular death in healthy patients .   
Hemostatic Factors: Fibrinogen 
The relation between increased levels of  fibrinogen and risk of vascular 
(and also acute coronery events) was linar. 
 
Microalbuminuria 
The  microalbuminuria ,  been found to be increasingly associated with 
stroke ,mi and other vascular events. 
Cystatin C 
Cystatin C which is  measurement  of renal function was to be associated 
with age, powerful  of risk of stroke, MI, and death from vascular causes in 
elderly and in some patients irrespective  creatinine 48. 
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HYPERHOMOCYSTEINEMIA AND STROKE: 
HOMOCYSTEINE: 
Homocysteine (2-amino-4-mercapto butyric acid) is a  sulfur-
containing amino acid from a nonprotein source;  it is not included in the 
structure of any protein and is  synthesized from methionine. Homocysteine 
is oxidized  rapidly in plasma and thus it can be found in many forms.  
Figure 3 HOMOCYSTEINE METABOLISM 
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Most of it is bound to albumin with a disulfide bond. The  rest is in 
unbound free disulfide and sulfhydryl forms.  Homocysteine exists at the 
junction point of 2 important  pathways and is regulated by many different 
enzymes. The destiny of homocysteine, between de  novo methionine 
biosynthesis and the transsulfuration pathway, is determined by                          
S-adenosylmethionine (SAM)  allosterically 
In the homocysteine remethylation cycle, at the  beginning, 5,10-
methylene-THF is reduced to 5-MTHF  by 5,10-methylene tetrahydrofolate 
reductase (MTHFR).  
This is a unique in vivo reaction that produces 5-MTHF. Vitamin 
B12-dependent methionine synthase then converts the homocysteine into 
methionine; in this process, 5-MTHF is transformed into THF. This final 
step requires methionine synthase reductase (MSR), which activates the 
methionine synthase by reducing it. In addition, homocysteine can be 
converted into methionine by betaine-homocysteine methyltransferase 
(BHMT), which is not dependent on vitamin B12. Subsequently, 
synthesized methionine is transformed into SAM, which is a general methyl 
donor for some important biomolecules, such as adrenaline, 
phosphatidylcholine, and carnitine, by methionine adenosyl transferase and 
ATP. The cycle is then completed with the transformation of SAM into           
S-adenosyl homocysteine (SAH), and later, back into homocystein E. 
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HYPERHOMOCYSTENEMIA AND DISEASES: 
Normal fasting plasma homoysteine  is from five  to fifteen  micro mol . 
Hyperhomocysteinemia is further classified as : 
Mild              -15-30  
Moderate       - 30- 100 
Severe            - > 100 
PATHOGENESIS OF HYPERHOMOCYSTENEMIA: 
EFFECT ON ENDOTHELIAL CELLS: 
 1it causes oxidation damage to vessels 
 2 decreases vascular relaxation  
 3causes  coagulation abnormality 
 Other possible mechanisms are: 
a) increased homocysteine releases oxidative free radicals which 
agments the atherosclerotic process.  
b) chronic  diseases sometimes causes elevation of homocysteine 
due to some immune activation 33 
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FACTORS AFFECTING SERM HOMOCYSTEINE LEVEL: 
It can be inherited or acquired 
INHERITED CAUSES: 
Primary hyperhomocystenemia 
Due to inherent deficienc of the enzymes involved inhe homocysteine 
metabolism. 
Cystathione beta synthase deficiency 
     It is  inherited as an autosomal recessive disorder .it is the 
commonest type of deficiency and is characterized by skeletal 
deformation ,mental retardation,lens dislocation and premature 
atherosclerosis. 
5,10 methylene tetra hydro folate reductase deficiency 
    This is common in european with a prevalence of about 12% .more 
prevalent in mediteranean region. This is due to mutatons in MTHFR  
gene mutations C677T  results in alanine valine substitution .it results 
in increased homocysteine level especially in the presence of low 
plasma folta level .another mutation in the MTHFR gene , A1298C 
resulting n glutamic acid to alanine substitution is also identified.but 
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the influence of this mtatiion in plasma homocystene levelis not 
clearly described till now 49. 
 
ACQUIRED CAUSES:   
Physiological 
Tobacco use 
Coffee consumption  
Vitamin deficiency like vitamin B2, B6,B12,folate 
 Systemic disorders-   
Liver disease 
Renal disease 
Diabetes mellitus 
Pernicious anema 
Sle 
Hypothyroidism 
Psoriasis 
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ALL 
Organ transplantation 
Malignancy of ovary ,breast 
Drugs- nicotine ,metformin , thiazide, nicotinic acid, 
folate  antagonist, vitamin B6 antagonist like oral 
contraceptives etc. 
Age and gender: 
In both men and women plasma homocysteine level increases with 
age .This age related changes ma be due to difference intake of nutrients 
like vitamin B6,B12 etc. premenopasal women the plasma homocysteine 
level is lower compared to men of same age .post menopausal women have  
higher plasma level compared to pre menopausal women .this may be due to 
influence of sex steroids. 
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Nutritional intake: 
Nutritional factors like decreased intake of vitamin B6,B 12,folate 
result in increasd homocysteine levels.This is important in strict vegetarians 
because vegetarian diet is usually low in vitamin B6 ,B 12.so individuals 
following vegetarian diet serum homocysteine level is found to be elevated  
Life style fators: 
Physical activity lowers homocystein level .increased caffeine intake 
and smoking causes increase in homocysteine level. Alcohol has variable 
effect on homocysteine level where as excessive intake results in increase 
plasma homocysteine level. This is attributed to changes in one carbon 
metabolism in excessive alcohol intake and also to deficiency of B-complex 
vitamins in chronic alcoholics. 
Liver disease 
Liver plays an important role in the synthesis and metabolism of 
homocysteine .in chronic liver disease there is increase in plasma 
homocysteine level. This is due to decreased availability and utilization of  
B complex vitamins and also decreased expression of genes involved in 
homocysteine metabolism in diseased liver 50. 
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Renal disease 
In patients with impaired renal function the levels of homocysteine and 
other sulphur containing amino acids will be increased. This is due to 
impaired excretion of homocysteine by diseased kidney and also there is 
impairment of extra renal metabolism of homocysteine 34. 
Diabetes mellitus 
In diabetic individuals onset of vascular disease is associated with 
increase homocysteine level, also insulin resistance is associated with 
increased homocystein level. Hyperhomoysteinemia increases the risk of 
vascular diseases in diabetics. 
Renal transplantation. 
Immunosupression used after renal transplantation like cyclosporine 
also plays an important role in increasing plasma homocysteine level .  
Homocsteine and malignancy: 
Elevated homocysteine  levels can be seen in various malignancy .it is 
more evident  in patients with cancer of the breast ,ovary, colon 
,prostate. This was demonstrated by james WU. He demonstrated that 
elevated homocysteine levels in these patients correlates with the level 
of tumor markers and decline with tumor regression during treatment. 
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Complications of hyperhomocysteinemia 
1.Ischaemic Heart Disease 
2. Cerebrovasclar Disease 
3.Venous Thromboembolism 
4. Central retinal artery occlusion 
5. Pre eclampsia 
6. Peripheral vascular diseases 
7. Hypertension 
8. Diabetes Vascular Complications 35 
Homocysteine and hypertension 
In 1969, McCully recognized the elevation in the concentration of 
plasma homocysteine can lead to an increased risk of  cardiovascular 
disease.  
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PATHOGENESIS OF HOMOCYSTEINE: 
It is now widely accepted that increased plasma homocysteine (Hcy) 
is associated with increased cardiovascular risk, independently of other 
atherosclerosis risk factors. From a pathophysiologic point of view, 
homocysteinaemia is associated with 
1)  Increased thrombogenicity, 
2)  Increased oxidative stress status, over activation of redox-sensitive 
inﬂammatory pathways 
3)  Impaired endothelial function,4 and 
4)  ﬁnally atherogenesis. 
 
HOMOCYSTEINE AS A RISK FACTOR FOR ATHEROSCLEROSIS: 
The role of homocysteine in atherosclerosis has been well elucidated. 
All the large meta-analyses conducted during the last decade yield 
consistent. homocysteine can be considered as an independent risk factor for 
cardiovascular disease (CVD). The first large meta-analysis published in 
1995 pointed out that homocysteine is strongly associated with vascular 
disease, arguing that an increment in total homocysteine by 5 mmol/L  
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Is equivalent to the elevation in CAD risk induced by a 20 mg/dL increase 
in plasma cholesterol.  Furthermore, it was suggested that Hcy accounts for 
up to 10% of the population’s CAD risk. 
 
Homocysteine and endothelial function 
                  Increasing evidence suggests that  homocysteine may increase 
cardiovascular risk as a result of its detrimental effect on endothelial 
function. In subjects with homocystinuria, a significant impairment of 
endothelium-dependent dilation (EDD) has been well documented, while 
homocysteine has been associated with impaired coronary microvascular 
dilator function in healthy individuals. Nevertheless, evidence is conflicting 
in mild homocysteinaemia. Not all observational studies have reported a 
statistically significant correlation between plasma Hcy and flow-mediated 
dilation of the brachial artery. 
 
HOMOCYSTEINE AND ENDOTHELIAL NITRIC OXIDE 
SYNTHASE REGULATION  
The close association of Hcy with endothelial dysfunction is largely 
dependent on its impact on. The uncoupled form of eNOS is a major source 
of superoxide radicals instead of nitric oxide, in the vascular wall. A 
decreased supply of endothelial substrate L-arginine, observed in 
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homocysteinaemia, has been demonstrated to induce endothelial nitric oxide 
synthase uncoupling in cell cultures of endothelial cells. 
  
HOMOCYSTEINE AND THROMBOTIC MECHANISMS  
The link between homocystinemia  and vascular thrombosis is now 
well established. Severe homocysteinaemia accompanying the genetic 
defects of homocystinuria is closely linked with recurrent vascular 
thrombosis. Half of the patients with homocystinuria will come up with a 
vascular event before the age of   However, it seems that the 
homocystinuria-related prothrombotic state mainly concerns veins rather 
than arteries. 
 
HOMOCYSTEINE-LOWERING TREATMENT AND VASCULAR 
FUNCTION 
Folic acid and vitamins B12 and B6 are essential co-factors in Hcy 
metabolism.5-MTHF, the circulating form of folic acid, serves as the 
methyl-donor in the conversion of  homocystene to methionine, an 
enzymatic reaction catalysed by MS. Vitamin B12 is also pivotally 
implicated in this reaction as it constitutes an essential co-factor of MS, 
whereas B6 is a co-factor for CBS, the enzyme responsible for the 
conversion of Hcy to cystathione and finally to cysteine. Therefore, 
conditions associated with 5-MTHF, B12, or B6 deficiency have been 
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associated with increased circulating Hcy levels, and these are the first 
therapeutic targets in the treatment of homocyateinaemia. 
Folate administration has been consistently shown to reduce plasma 
Homocysteine even in healthy individuals without elevated Homocysteine  
levels. Oral administration of folic acid (0.5–5.0 mg/day) reduces fasting 
Homocysteine  levels by 25–30%, while supplementation with vitamin B12 
(0.02–1 mg/day) yields an additional 7% reduction in levels. Vitamin B6 
has no effect on fasting Homocysteine  levels but significantly lowers post-
methionine loading homocysteinaemia.  
 
HOMOCYSTEINE LOWERING AND ENDOTHELIAL FUNCTION 
Hcy lowering by folates and vitamins B6 and B12 induce a significant 
improvement of vascular NO bioavailability and the overall endothelial 
function by decreasing plasma Hcy, which is a pro-oxidant molecule in 
human vasculature as we have already discussed. Notably, evidence 
suggests that folic acid may reverse vascular dysfunction independently of 
Homocysteine  lowering. In a recent double-blind crossover trial, high-dose 
folic acid (10 mg/day) improved endothelial function in patients post-
myocardial infarction, independently of any changes in plasma Homocsteine  
levels (including total, reduced, or oxidized forms). These findings support 
our previous observations that folic acid and its circulating metabolite               
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5-MTHF have direct effects on vascular function in humans, independently 
of any  effects on oxidized or reduced plasma Homocysteine . 
 
                Oral folic acid administration(0.4 or 5 mg/day), 7 weeks before 
scheduled CABG, was combinedwith improved vasomotor responses of the 
grafts (saphenous veins and internal mammary arteries), reduced vascular 
superoxide production, and improved endothelial nitric oxide synthase 
coupling . 
 
HOMOCYSTEINE LOWERING AND BIOCHEMICAL MARKERS 
OF ENDOTHELIAL FUNCTION AND OXIDATIVE STRESS 
Both chronic and acute, experimentally induced, homocysteinaemia 
are associated with increased oxidative stress and impaired endothelial 
function in humans. Folate administration in chronic homocysteinaemia is 
known to reduce pro-thrombotic state, raise antioxidant defensive 
mechanisms, and lower systemic oxidative stress markers. Concomitant 
administration of high doses of antioxidant vitamins in the model of 
experimental, methionine-induced homocysteinaemia prevented the increase 
of inflammatory markers such as IL-6.43. 
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HOMOCYSTEINE-LOWERING TREATMENT AND CLINICAL 
OUTCOME: ITS ROLE IN PRIMARY AND SECONDARY 
PREVENTION 
 
The available data for the role of homocysteinaemia in CVD reasonably 
posed the question of reducing cardiovascular risk through homocysteine 
lowering therapy-lowering treatment by means of diet folate 
fortification.Remarkable results were derived from a recently published 
study that examined the effect of folate fortification of flour in  The study 
showed that folate fortification increased circulating plasma folate levels 
and reduced plasma homocysteine  in the general population. 
 Importantly, since 1998, when the flour fortification programme with folate 
(150 mg folate per 100 g flour) became fully mandatory, an accelerated 
reduction in stroke mortality was observed in North America. In addition, 
this reduction in mortality was analogous to that predicted by Hcy lowering. 
However, the same tendency was not observed in Wales and England, 
where folate fortification was not introduced. Although a causative 
relationship between Homocysteine, folate, and stroke cannot be deduced 
from these epidemiological observations, the available data are in favour of 
the hypothesis that folate fortification contributes to the reduction of stroke 
mortality, at least at the level of primary prevention.  
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HOMOCYSTEINE AND CARDIOVASCULAR RISK: FUTURE 
PERSPECTIVES 
 It is now widely accepted that, at a cellular level, Homocysteine exerts a 
detrimental effect on vascular wall and especially on endothelial cells, by 
decreasing NO bioavailability, increasing intracellular oxidative stress, and 
by triggering multiple pro-atherogenic mechanisms. In this context, 
epidemiological studies have clearly demonstrated that plasma 
homocysteine is an independent risk factor for atherosclerosis. The existing 
data clearly demonstrate that moderate/ severe homocysteinaemia is 
associated with thromboembolic events and increased risk for 
atherothrombosis, and it should be treated with folic acid/B vitamins. 
However, it is still unclear whether homocysteine -lowering treatment with 
folic acid/B vitamins  has the potential to improve clinical outcome in 
subjects with mild homocysteinaemia, and the debate on whether 
Homocysteine lowering treatment with folate has a role in primary or 
secondary prevention in subjects with plasma Hcy within the normal range 
is still unresolved 44. 
Hyperhomocystenemia and stroke: 
In a study conducted by  Venkata  Madhav ,  Anjaneya Prasad  Pradeep 
Babu KV in tamil nadu .Homocystene levels were found to be 
significantly higher in cerebral ischemic stroke patients by  41.8%. 
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71.7% of cerebral ischemic stroke patients belong to 41 – 60 years age 
group. Male to female ratio were  found to be 1.66: 1.high incidence of 
hyperhomocystenemia in 56.25% of cerebral ischemic stroke patients 
without risk factors than patients with hypertension, diabetes, 
dyslipidemia and smoking associated incidence of 
hyperhomocystenemia in 34.4% of cerebral ischemic stroke patients. 
Elevated serum homocysteine is a strong and modifiable risk factor of 
cerebral ischemic strokes. Many studies are showed the significance of 
development of complications like cardiac and cerebral vascular events. 
We support the consideration of serum  homocysteine as a regular and 
routine screening marker to protect target organ damage 36. 
MANAGEMENT OF STROKE: 
INVESTAGATIONS: 
1. CONFIRM THE DIAGNOSIS 
Computerised tomography (CT scan) 
All patients should have a CT scan, urgently if  
-  conscious level depressed 
- diagnosis uncertain 
- on anticoagulants 
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- before commencing/resuming anthitrombotics 
- if thrombolysis is considered 
Infarction is evident as a low density lesion which conforms to a vascular 
teritory. Subtle changes occur within 3 hours in some pts; most scans 
become abnormal within 48 hours.    
Figure 4 CT BRAIN SHOWING INFARCT 
 
CT BRAIN SHOWING HEMORHAGE 
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Figure 5 
 
Magnetic resonance imaging: T2 prolongation (hyperintensity in 
relation to white and grey matter) occurs within hours of onset of ischemic 
symptoms. 
Advanced technique, diffusion weighted imaging (DWI) and 
perfusion imaging (PWI) show respectively early infarction (cytotoxic 
oedema) and ischaemic tissue at risk (‘ischaemic penumbra’). 
These advanced techniques are valuable predictors of outcome and 
guide treatments directed as thrombolysis. 
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Figure 6 MULTIMODAL DIFFUSION –PERFUSION MRI 
 
DEMONSTRATE THE SITE OF PRIMARY LESION 
a) Non-invasive investigation 
    Ultrasound – Doppler/Duplex scanning: assesses extra- and 
intracranial vessels.  
Figure 7 CARTID DUPLE 
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DEMONSTRATE THE SITE OF PRIMARY LESION 
a)  Non-invasive investigation 
     Computed tomographic angiography (CTA) – dynamic helical CT, 
following bolus injection of non-ionic contrast, can be used to 
investigate both intracranial and extracranial vasculature.  
       CTA compared with DSA correctly classifies the degree of carotid 
stenosis in 96% of cases but is insensitive to ulcerative plaques.It is best 
used in conjunction with Doppler.  
Figure 8 CT ANGIO 
 
DEMONSTRATE THE SITE OF PRIMARY LESION 
a)  Non-invasive investigation 
     Magnetic resonance angiography (MRA) – ‘Time of flight’ or 
contrast enhanced techniques are used. It tends to overestimate the 
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severity of stenosis. When assessing the carotid arteries it is best used in 
combination with Doppler. 
 Its non-invasive nature makes it helpful in investigating the 
intracranial circulation. 
Figure 9 MR ANGIOGRAM 
MRA
 
DEMONSTRATE THE SITE OF PRIMARY LESION 
b) Digital intravenous subtraction angiography (DSA) 
Figure 10 
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 IDENTIFY FACTORS WHICH MAY INFLUENCE 
TREATMENT AND OUTCOME 
- General investigation 
- Chest X-ray (cardiac enlargement, HT,…) 
- ECG (cardiac disease) 
- Blood glucose (diabetes) 
- Serum lipids and cholesterol (hyperlipidemia) 
- Full blood count (polycythaemia, thrombocytopenia) 
- Urine analysis (polyarteritis, thrombocytopenia) 
- Auto-antibodies  
- Prothrombin time and partial thromboplastin time (PTT) 
- Note drug history (oral contraceptives, amphetamines,…) 
- Selectively cardiac ultrasound, HIV screen, viscosity studies, 
anticardiolipin antibodies,  
- Serm homoysteine 
TREATMENT: 
Therapies for stroke prevention and management are designed to (1) 
prevent first stroke (primary prevention), (2) optimize functional recovery 
following stroke, and (3) avert stroke recurrences (secondary prevention). 
Specific measures for treatment and prevention depend upon the patient's 
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risk factors and stroke mechanism. Diagnostic evaluation of the stroke 
patient is therefore the key to determination of optimal therapy. 
PRIMARY PREVENTION OF STROKE 
Randomized trials have demonstrated the benefits of specific interventions 
to prevent a first stroke among patients with stroke-risk factors (Table 46.1). 
Treatment of hypertension, for example, is associated with up to a 45% 
reduction in the risk of stroke.  
ACUTE ISCHAEMIC STROKE: 
Attention is directed toward preventing the common complications of 
bedridden patients—infections (pneumonia, urinary, and skin) and deep 
venous thrombosis (DVT) with pulmonary embolism. Many physicians use 
pneumatic compression stockings to prevent DVT; subcutaneous heparin. 
Water restriction and IV mannitol may be used to raise the serum 
osmolarity, but hypovolemia should be avoided as this may contribute to 
hypotension and worsening infarction. Combined analysis of three 
randomized European trials of hemicraniectomy (craniotomy and temporary 
removal of part of the skull) shows that hemicraniectomy markedly reduces 
mortality, and the clinical outcomes of survivors are acceptable 37. 
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INTRAVENOUS THROMBOLYSIS: 
In a study rtPA was given to stroke patients presenting within three hours 
and it was   compared with placebo. Stroke patients treated with rtpa had a 
better outcome compared to placebo group. 
RECOMBINANT TISSSUE PLASMINOGEN ACTIVATOR IN 
STROKE  
Indications : 
Clinical diagnosis of stroke 
Within three hours from symptom onset to drug administration 
CT scan showing without an bleed or  
Age >18 years 
Consent obtained from the patient. 
Contraindications: 
 1.elevated blood pressure  more than 185 systolic and 110 diastolic despite 
treatment 
 2.Platelets less than hundred thousand  ;hematocrit less than twenty five 
percent ;  
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 3.when heparin is used within two days. 
4.symptoms which has improved very fast. 
5.history of head injury within 3 months 
6.major surger within fourteen days 
 7.less severe stroke symptoms 
8.GI hemorrhage within twenty one days. 
9.Recent MI 
10 .Coma , stupor 38 
ENDOVASCULAR TECHNIQUES: 
Ischemic stroke from large-vessel intracranial occlusion results in high rates 
of mortality and morbidity. Occlusions in such large vessels [middle 
cerebral artery (MCA), internal carotid artery, and the basilar artery] 
generally involve a large clot volume and often fail to open with IV rtPA 
alone 39.  
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ANTITHROMBOTIC TREATMENT: 
ASPIRIN: 
; there are several antiplatelet agents proven for the secondary prevention of 
stroke .and aspirin is the approved drug so far 40 . 
ANTICOAGULATION: 
Numerous clinical trials have failed to demonstrate any benefit of 
anticoagulation in the primary treatment of atherothrombotic cerebral 
ischemia. Use of SC unfractionated heparin versus aspirin was tested in IST. 
Heparin given SC afforded no additional benefit over aspirin and increased 
bleeding rates. Several trials of LMWHs have also shown no consistent 
benefit in AIS. Furthermore, trials generally have shown an excess risk of 
brain and systemic hemorrhage with acute anticoagulation.  
NEUROPROTECTION: 
Neroprotection has been found to enhance brain s capacity to withstand 
ischaemia.It acts by actively blocking brains excitatory amino acid s and 
was proved in animal models. Human studies were not promising. 
Hypothermia was found to have a good outcome in cardiac arrest patients 
but not in CVA 41. 
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REHABILITATION: 
Proper rehabilitation may redce mortalit and morbidity due to stroke . 
Stroke teams must be working round the clock in managing patients with 
stroke . 
The goal of rehabilitation is to make the patient recover from deficit by 
physiotherapy and return home with minimal deficit. This finding suggests 
that the human nervous system is more adaptable than originally thought 
and has stimulated active research into physical and pharmacologic 
strategies that can enhance long-term neural recovery 42. 
HEMORHAGIC STROKE : 
Emergency management: 
Close attention should be paid to airway management since a reduction in 
the level of consciousness is common and often progressive. The initial 
blood pressure should be maintained until the results of the CT scan are 
reviewed.  
Intra cerebral bleed: 
Nearly 50% of patients with a hypertensive ICH die, but others have a good 
to complete recovery if they survive the initial hemorrhage. The ICH 
scoring system  is a validated metric that is useful for prediction of mortality 
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and clinical outcomes. Any identified coagulopathy should be reversed as 
soon as possible. For patients taking VKAs, rapid reversal of coagulopathy 
can be achieved by infusing prothrombin complex concentrates which can 
be administered quickly, followed by fresh-frozen plasma and vitamin K.  
TREATMENT  HYPERHOMOCYSTENEMIA IN YOUNG STROKE: 
Sinc homocysteine depends on folic acid and vitamin b twelve for its 
metabolic pathway supplementation of these two vitamins could actually 
redce the event of stroke and recurrent stroke. 
But Some studies showed that suplementaion of vitamin did not decrease 
the stroke events and its recurrence the reason for this could not be 
explained .  
                                    
 
 
 
 
 
 
 
 
83 
 
 
MATERIALS AND METHOD 
 
SETTING         :    INPATIENTS, 
                                          THANJAVUR MEDICAL    COLLEGE HOSPITAL,  
                THANJAVUR 
                                                                                                                    
ETHICAL COMMITTEE APPROVAL : YES OBTAINED 
DESIGN OF STUDY     :    OBSERVATIONAL      AND PROSPECTIVE 
 SINGLE CENTRED STUDY 
PERIOD OF STUDY      : December 2013 to june 2014 
 
SAMPLE SIZE              :  50 PATIENTS 
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                           SELECTION OF PATIENTS        
INCLUSION CRITERIA                                                            
PATIENTS WITH  YOUNG STROKE 
 
EXCLUSION CRITERIA                                                            :    
young stroke patients with the following risk factors were excluded 
from the study. Patients with 
                                                   1. DIABETES MELLITUS 
                                                   2.HYPERTENSION 
                                                   3. SMOKING 
                                                   4. ALCOHOLISM 
                                                   5.HYPERLIPEDEMIA 
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STUDY METHODOLOGY 
50 patients with young stroke were selected for the study. Patients  
having  Conventional risk factor like hypertension ,diabetes mellitus, 
smoking, hyperlipedemia,  alcoholism  were  excluded  from  the  study 
Diagnosis of stroke was based on history ,clinical features, ct brain and in 
some patients  MRI brain. 
The following investigations were done on admission: 
1.complete blood count 
2.random blood sugar 
3.serum cholesterol 
4.serum triglyceride 
5.blood urea 
6.serum creatinine 
7.fasting serum homocysteine level 
8.HIV 
9.VDRL 
10.ECG 
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11.CT BRAIN 
12.CAROTID DOPPLER 
13.ECHOCARDIOGRAM 
MEASUREMENT OF SERUM HOMOCYSTEINE: 
Serum homocysteine is measured by fluorescein polarization 
immunoassay(FPIA) 
Principle of the procedure: 
First the bound homocysteine present in serum is reduced by the use of 
dithiothreitol(DTT).then the free homocysteine is converted to S- adenosyl 
homocysteine (SAH) by the use of enzyme S-ADENOSYL homocysteine 
hydrolase and adenosine 
HOMOCYSTENE +ADENOSINE               SAH + H2O 
This mixture containing  SAH , antibody , FPIA diluents buffer and a tracer 
tagged  with a fluorescent chromophore were added to the cuvette.there will 
be competition between SAH from the serum sample and the fluorescent 
tagged tracer to bind the antibody.then the intensity of the polarised light is 
measuredusing FPIA optical assembly 
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Specmen collection and storage : 
4 ml of blood was collected  in EDTA coated tubes.samples are stored at 2-8 
degrees if testing is delayed.the serum is separated by centrifugation: 
 
    
 
 
                         
 
 
 
 
 
 
                              
 
 
 
 
88 
 
 
 
OBSERVATION AND RESULTS: 
50  patients  with young were included in the sudy. Serum homocysteine 
level were measured and results were analysed: 
   YOUNG  STROKE PATIENTS : 
50  young  stoke patients  were included in the study. Serum homocyteine  
levels were measured and results were analysed.among 50 patients  39 were 
males and 11 were females.male preponderenc was seen. 
TABLE 1 SEX DISTRBUTION IN YOUNG STROKE PATIENTS 
Sex Number of patients Percentage 
Male 39 78 
Female 11 22 
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Figure 11 
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AGE GROUP: 
The maximum age limit of Patients included in the study were < 45. Mean 
age group of patients included in the study is 30.  
TABLE 2  AGE DISTRIBUTION IN YOUNG STROKE PATIENTS 
                Age group      Number  OF patients                  Percentage% 
 15  - 20                            2                           4 
20  - 25                            5                         10 
25-   30                           15                         30 
30-  35                           19                         38 
35 - 40                            5                         10 
40-45                             4                           8 
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Figure 12 
 
 
 
Figure 13 
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           STROKE PATIENTS WITH ELEVATED HOMOCYSTEINE: 
Of the  50 patients included in the study 32 patients had elevated  
homocysteine and 18 patients  homocysteine were within normal limit. 
Hence the study shows an increased incidence of stoke in patients with  
elevated homocysteine. 
TABLE 3 STROKE PATIENTS WITH ELEVATED HOMOCYSTEINE  
SERUM  
HOMOCYSTEINE 
LEVEL 
Number of patients Percentage 
NORMAL 18 36% 
ELEVATED 32 64 % 
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Figure 14 
 
Figure 15 
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TABLE 4 Hyperhomocysteinemia  statistical  significance  
 
 
Homocysteime No.of respondents (n=50) 
Percentage 
(100%) 
Below 15 18 36.0 
Above 15 32 64.0 
 
 
                                                
                                 TABLE 5                      T-Test 
 
Homocysteim
e 
Mea
n S.D 
Statistical 
inference 
Below 15 
(n=18) 
7.923
9 3.61025 
T=-7.026 
Df=48 
.000<0.05 
Significant 
Above 15 
(n=32) 
32.00
16 14.22459  
 
This shows it is statistically significant . 
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AGE DISTRIBTION OF HYPERHOMOCYSTEINEMIA: TABLE 6 
                Age group               No OF 
PATIENTS 
                 Percentage 
 15  - 20                      2                                 6.25 
20  - 25                      4                            12.5 
25-   30                       7                            21.85 
30-  35                       12                            37.5 
35 – 40                        3                            9.37 
40-45                     4                               12.5 
 
Figure 16 
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Sex  distribution of patients with elevated homocysteine: 
Among  32 patients(64%) with elevated homocysteine  24 were males and 
remaining  8 were females . this shows  male preponderance. 
TABLE 7 SEX DISTRIBUTION IN PATIENTS OF ELEVATED 
HOMOCYSTEINE  
                         sex                  no  Percentage 
Male                 24  75 % 
Female                   8  25% 
 
Figure 17 
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TYPE OF STROKE : 
Young  stroke Patients with elevated homocysteine had ischaemic, 
hemorrhagic stroke or cortical vein thrombosis. In our study out of 32 
patients with elevated serum homocysteine  there wsa 1 hemorhagic stroke 4 
CVT, and the remaining 27 patients  had  ischaemic  stroke. 
 
TABLE 8 TYPE OF STROKE IN HYPERHOMOCYSTENEMIA 
GROUP 
TYPE OF STROKE NUMBER PERCENTAGE 
ISCHAEMIC 27 84% 
HAEMORRHAGIC 1 3% 
CORTICAL VENOUS 
THROMBOSIS 4 13 % 
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Figure 18 
 
 
All the 4 patients with CVT in the elevated homocysteine group were 
females indicating CVT  was more common among females in young stroke 
patients  presenting as CVT. 
 
YOUNG STROKE PATIENTS  WITH ELEVATED HOMOCYSTEINE  
VS NORMAL HOMOCYSTEINE : 
Average serum homocysteine level in patients of young stroke with elevated 
homocysteine  is 34.58  .the average homocysteine  level in young stroke  
patients  with normal range homocysteine is 11.8 
 
84%(ISCHAEM
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TABLE 9 AVERAGE HOMOCYSTEINE LEVEL BETWEEN TWO 
GROUPS 
 
HOMOCYSTEINE       AVERAGE HOMOCYSTEINE 
 ELEVATED GROUP                      34.58 
NORMAL  GROUP                      11.8 
 
Figure 19 
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DISCUSSION 
Many studies have showed that increased serum  homocysteine level  
represents an  independent risk factor for coronary, cerebrovascular and 
peripheral arterial disease. 
Hyperhomocysteinemia is one of the newly recognized factor that increases 
the risk of vascular disease. Mechanisms by which hyperhomocysteinemia 
increases risk of cerebrovascular accidents are not clear, but several possible 
mechanisms have been proposed. Hyperhomocysteinemia is associated with 
atherosclerosis. 
Experimental studies both in vivo and in vitro shows that homocysteine 
causes endothelial injury and cell detachment. 
Measurement of homocysteine may become the integral part of workup of  
young stroke patients in future. Of the 50 patients  studied 32 patients had 
elevated serum homocysteine  and 18 patients had homocysteine within 
normal limit. This shows increased homocysteine was elevated in majority 
of young stroke patients without the conventional risk factors. 
           In our study hyperhomocysteinemia was more common in males 
compared to females . Our findings were consistent with study of Narang et 
al2, Modi et al6, Bogdan et al10 and Andrew et al published in neurology 
journal 53. . 
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However Kang et al studies shows that young healthy women have  
homocysteine levels lower than healthy men. This difference diminishes 
with ageing.  An abrupt increase in serum homocysteine in women after 50 
years suggests that sex difference in homocysteine disappears with 
increasing age. 
           In our study of young stroke patients  no of patients with infarct was 
around 86 percent and that of hemorrhagic stroke was 3 percent and that of 
CVT was 13percent. Our findings were consistent with study of Datta et al 
and Boysen et al where serum homocysteine levels were significantly raised 
in infarcts when compared to hemorrhage. 
Clarke R et al, Olsegun et al, Osunkalu et al, Kittner et al, Bruce et al, Perry 
et al and Zongte et a concluded hyperhomocysteinemia as an independent 
predictor of stroke risk (both infarct and hemorrhage). 
 Modi et al, Roudbari et al and Nigel et al concluded that 
hyperhomocysteinemia as an important  risk factor ischemic stroke 52. 
Hyperhomocystenemia is associated with recurrent stroke  according a 
journal published in  Stroke. 2003 May;34(5):1258-61. Epub 2003 Apr by 
Boysen G1, Brander T, Christensen H, Gideon R, 1Department of 
Neurology, Bispebjerg Hospital, 2400 Copenhagen NV, Denmark  51. 
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 Individuals with  ischemic  stroke and hyperhomocysteinemia may benefit 
from HLT(homocysteine lowering therapy) for secondary prevention 
according to  VITATOPS  . 
 
         In our study  we excluded patients with conventional risk factors and 
included  only  patients without  those  risk  factors  and evaluvated  
whether  hyperhomocysteinemia  has a role independent risk factor for 
stroke.We found that significant number of patients had 
hyperhomocystenemia .hence  hyperhomocstenemia  is an emerging  
independent  risk factor  for stroke in our study. 
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                                              CONCLUSION: 
1) Our study shows hyperhomocystenemia in majority of young stroke 
patients  around 64% who did not have the conventional risk factors like 
diabetes mellitus ,hypertension , hyperlipedemia, and other risk  factors like 
smoking and  alcohol. 
2) Our study shows that young stroke patients with hyperhomocystenemia  
were more commonly found in the age group of  30-35 and the common age 
group of patients of young stroke with or without hyperhomocystenemia 
was also in the same age group.  
3) Our study also shows that hyperhomocstenemia as a cause of young 
stroke  was more common   among males compared to females. 
4) Since hyperhomocystenemia is associated with increased incidence of 
young stroke and recurrent stroke large group of well organized study 
studies has to be conducted to find out whether homocysteine lowering 
therapy with high dose folic acid,pyridoxine and vitamin b12 reduces the 
incidence of young stroke and   recurrent stroke . 
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CONSENT FORM 
 
 I __________________________________________  hereby give 
consent to participate in the study conducted by DR.K.SATHYASAGAR, 
post graduate in department of internal medicine ,thanjavur medical college 
& hospital, thanjavur – 613001 and to use my personal clinical data and 
result of investigation for the purpose of analysis and to study the nature of 
disease. I also give consent for further investigations 
 
Place : 
Date :       Signature of participant 
 
 
 
 
 
 
                           
  
PROFOMA 
 A STUDY OF CLINICAL  PROFILE  AND  SERM  
HOMOCYSTEINE  LEVEL- YOUNG STROKE EXCLUDING THE 
RISK FACTORS  SMOKING, ALCOHOL, 
HYPERCHOLESTROLEMIA,HYPERTENSION,DIABETES 
MELLITUS. 
 
NAME :                                                                 IP     : 
AGE     :                                   DOA:                    DOD: 
PRESENTING ILLNESS: 
 
PAST HISTORY: 
DIABETES               : 
HYPERTENSION    : 
STD                         : 
PERSONAL HISTORY  
SMOKING              : 
ALCOHOLISM        : 
  
FAMILY HISTORY  : 
OTHERS                  : 
CLINICAL EXAMINATION: 
GENERAL EXAMINATION: 
BP                    PR: 
CNS:     
HMF                      : 
CRANIAL NERVES: 
MOTOR:                  POWER     BULK   TONE   DTR                                                        
R    
L      
SENSORY SYSTEM: 
SPINE AND CRANIUM: 
CVS:                                     
RS:                                                                   ABDOMEN: 
RS: 
PA: 
  
INVESTIGATIONS 
CBC:                                                                       BLOOD SUGAR  :         
HB-                                                                                                                   
RBS - 
TC-                                                                                                                    
FBS - 
DC-                                                                                                                   
PPBS - 
PCV-                                                                                                        
BLOOD UREA:                      
SERUM CREATININE: 
ESR-                                                                                                        
LIPID PROFILE  : 
PLATELET-                                     
Sr cholesterol: 
RBC        TG:     
HDL:            LDL:          VLDL    
 
  
HIV: 
VDRL: 
ECG: 
CT BRAIN: 
MRI: 
CAROTID DOPPLER: 
SERUM HOMOCYSTEINE: 
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1 marimuthu 35 m no no no no no 87 170 24 0.6 16.3 NR WNL wnl infarct 
NO 
RWMA
 NIL NIL NIL 11 120/70
 rajini 34 m no no no no no 110 36 1.2 22.4 nr wnl infarct
no 
rwmA
nil nil nil 9 140/90-
3 vajithabanu 22 f no no no no no 100 160 116 26 0.8 24.3 nr nr wnl infarct infarct normal
no 
rwma
nil nil nil 10 100/60
4 kavitha 24 f no no no no no 134 155 140 42 0.9 42.7 nr nr wnl wnl
infarct 
ant 
normal norwma nil nil nil 10 130/90
5 ayyapan 26 m no no no no no 112 155 123 45 1 36.8 nr nr wnl infarct infarct normal wnl nil nl nl 12 120/70
6 durai 29 m no no no no no 95 143 145 26 0.9 17 nr nr wnl infarct normal normaL NIL NIL nil 9 150/100
7 stella marry 30 m no no no no no 100 136 120 34 1.2 33 nr nr wnl cvt sst normal normal nil nil nil 7.8 120/90
8 manikandan 36 m no no no no no 112 120 110 28 0.9 26 nr nr wnl infarct normal normal nil nil nil 11 110/80
9 kamal raj 27 m no no no no no 98 150 128 38 0.7 7.13 nr nr wnl infarct normal normal nil nil nil 8 120/70
10 raja 30 m no no no no no 100 176 120 40 0.9 12 nr nr wnl infarct normal normal nil nl nil 9 130/90
11 ajith 16 m no no no no no 88 150 144 24 1 45 nr nil wnl infarct normal normal nil nl nil 11 120/70
12 aparna 20 f no no no no no 100 112 110 32 0.7 11 nr nil wnl infarct normal normal nil nil nil 12 130/90
13 vijaguru 30 m no no no no no 112 156 128 27 0.6 32.12 nr nr wnl infarct normal normal NIL NIL NIL 10 110/70
14 kamal 30 m no no no no no 207 112 110 42 0.9 42.12 nr nr wnl infarct normal normal nil nil nil 7.6 100/60
15 selvaraj 29 m no no no no no 118 134 112 34 1.2 12 nr nr wnl infarct normal normal nil nil nil 12 108/80
16 jayalakshmi 26 f no no no no no 120 160 120 38 1.4 70.8 nr nr wnl infarct normal normal nil nil nil 8 120/90
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17 ramkumar 33 m no no no no no 112 128 130 39 1 52.96 nr nr wnl infarct normal normal nil nil nil 10 110/70
18 pandiyaraj 42 m no no no no no 78 120 130 22 0.7 10 nr nr wnl infarct normal normal NIL NIL NIL 10 120/80
19
mohammed 
aslam
32 m no no no no no 88 112 155 26 0.6 3.26 nr nr wnl infarct normal normal nil nil nil 11 110/80
20 kamaraj 24 m no no no no no 98 140 160 40 0.8 42.42 nr nr wnl infarct normal normal nil nil nil 8 110/80
21 surya prakash 24 m no no no no no 120 120 145 48 1.5 24 nr nr wnl infarct normal normal nil nil nil 12 140/8
22 latha 32 f no no no no no 128 120 124 52 1 27.8 nr nr wnl infarct normal normal nil nil nil 130/80
23 lakshmi 26 f no no no no no 100 140 140 36 1.3 12.8 nr nr wnl ?cvt cvt normal normal nil nil nil 10 100/60
24 sekar 40 m no no no no no 106 128 140 36 2 32.3 nr nr wnl infarct normal normal nil nil nil 11 110/70
25 chinapan 28 m no no no no no 82 140 160 27 1.4 11.6 nr nr wnl infarct normal normal NIL NIL NIL 9 120/90
26 bakyaraj 32 m no no no no no 91 112 150 44 0.4 40 nr nr wnl infarct normal normal nil nil nil 8 130/90
27 ramakrishnan 25 m no no no no no 110 130 170 42 0.9 2 nr nr wnl infarct normal normal nil nil nil 9 120/80
28
joseph 
sagayaraj
33 m no no no no no 132 140 40 1 22.4 nr nr wnl infarct normal normal nil nil nil 10 140/90
29 fathima 28 f no no no no no 100 148 140 33 1 66.4 nr nr wnl wnl cvt normal normal nil nil nil 11 130/90
30 govindaraj 37 m no no no no no 76 180 140 36 1 18.9 nr nr wnl infarct normal normal NIL NIL NIL 10 126/90
31 tamiarasan 33 m no no no no no 120 170 150 29 1 22.3 nr nr wnl infarct normal normal nil nil nil 9 110/80
32 lakshmana 29 m no no no no no 88 162 130 45 0.8 4.2 nr nr wnl infarct normal normal nil nil nil 9 120/70
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33 appadrai 40 m no no no no no 98 150 128 35 0.7 32.6 nr nr wnl infarct normal normal nil nil nil 10 110/60
34 pandiyan 34 m no no no no no 103 160 140 44 0.7 30.3 nr nr wnl
hemorh
age
normal normal nil nil nil 11 120/80
35 charlatha 26 f no no no no no 110 170 10 48 0.9 28.63 nr nr wnl infarct normal normal nil nil nil 12 130/80
36 bharathi 32 f no no no no no 102 156 130 37 1.3 18.6 nr nr wnl infarct normal normal nil nil nil 10 110/70
37 GOPINATH 26 M no no no no no 115 142 120 38 1 18.72 nr nr wnl infarct normal normal NIL NIL NIL 10 120/80
38 HARISH 18 M no no no no no 110 145 130 26 0.8 55.42 nr nr wnl infarct normal normal nil nil nil 10 100/60
39 ARPUTHARAJ 31 M no no no no no 110 170 120 27 0.7 18.76 nr nr wnl infarct normal normal nil nil nil 11 108/70
40 RAJA 27 M no no no no no 120 188 110 28 0.6 22 nr nr wnl infarct normal normal nil nil nil 10 `110/70
41 elangovan 37 m no no no no no 97 210 169 22 0.6 7.51 nr nr wnl
hemorh
age
normal normal nil nil nil 9 120/80
42 megaraj 32 m no no no no no 87 122 43 0.7 8.36 nr nr wnl infarct normal normal NIL NIL NIL 10 140/90
43 veeramani 34 M no no no no no 100 166 130 43 0.8 11.4 nr nr wnl infarct normal normal nil nil nil 10 120/80
44
mohamedibra
him
30 m no no no no no 76 180 140 27 0.9 9.2 nr nr wnl infarct normal normal nil nil nil 8 110/60
45 manivel 27 m no no no no no 89 144 115 32 1.4 3.26 nr nr wnl infarct normal normal nil nil nil 9 110/80
46 munusamy 39 m no no no no no 110 178 136 40 1.2 7.51 nr nr wnl infarct normal normal nil nil nil 8 120/90
47 sivanandham 30 m no no no no no 100 159 137 25 1.8 2.56 nr nr wnl infarct normal normal nil nil nil 11 112/80
48 mthlakshmi 28 f no no no no no 84 170 138 30 1 6.84 nr nr wnl infarct normal normal nil nil nil 12 120/90
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49 pakirisamy 41 m no no no no no 88 166 120 28 1 22 nr nr wnl infarct normal normal nil nil nil 12 110/80
50 poovarasu 34 m no no no no no 102 145 135 32 0.9 19 nr nr wnl infarct normal normal nil nil nil 10
